Sort
141,003 grants matching “cytokine”
The Impact of Tolerance in the Newborn on Lentiviral Infection
$740,981Joseph M McCune · University Of California, San Francisco · R01 · FY2012 · AI
Timing of ART and homeostasis of the persistent HIV reservoir in the adult
$740,979Peter W Hunt · University Of California, San Francisco · R01 · FY2016 · AI
Inflammation and Cancer
$740,964Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Altering Sedation Paradigms to Improve Brain Injury and Survival in Severe Sepsis
$740,946Pratik Pandharipande · Vanderbilt University Medical Center · R01 · FY2017 · HL
A dual-acting small molecule for the treatment of type 1 diabetes
$740,897Shiyong Wu · Asake Biotechnology, Llc · R42 · FY2024 · DK
Brain signature of SARS-CoV-2 Infection and its impact on long-term cognitive functioning in older adults
$740,897Giovanni Schifitto · University Of Rochester · R01 · FY2024 · AG
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$740,894Gary K Owens · University Of Virginia · R01 · FY2021 · HL
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$740,894Gary K Owens · University Of Virginia · R01 · FY2020 · HL
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$740,894Gary K Owens · University Of Virginia · R01 · FY2019 · HL
Methamphetamine Activation of Inflammasome and Altered immunity in HIV (MAIA) Study
$740,880Susan Pereira Ribeiro · Emory University · R01 · FY2024 · DA
Deferoxamine for the Prevention of Acute Kidney Injury
$740,876David Evan Leaf · Brigham And Women'S Hospital · R01 · FY2020 · DK
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$740,856Petros C Karakousis · Johns Hopkins University · R01 · FY2023 · AI
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
$740,837Benjamin George Keselowsky · University Of Florida · R01 · FY2025 · AI
Chikungunya Virus Replication and Pathogenesis
$740,822Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
TTL - A NEW CLASS OF ORAL TNF-ALPHA SYNTHESIS INHIBITORS
$740,800Nereus Pharmaceuticals, Inc. · R44 · FY2002 · AI
Mitochondrial metabolism and macrophage function post MI
$740,793Rong Tian · University Of Washington · R01 · FY2020 · HL
Mitochondrial metabolism and macrophage function post MI
$740,793Rong Tian · University Of Washington · R01 · FY2022 · HL
Mitochondrial metabolism and macrophage function post MI
$740,793Rong Tian · University Of Washington · R01 · FY2021 · HL
mTOR as a Central Regulator of iMCD Pathogenesis and Novel Therapeutic Target
$740,743David C Fajgenbaum · University Of Pennsylvania · R01 · FY2019 · HL
Probing The Dark Matter of the Genome in the NHLBI Family Heart Study
$740,725Michael A Province · Washington University · R01 · FY2015 · HL
SIV-induced Inflammation Causes Functional Impairment of the PNS
$740,714Joseph L Mankowski · Johns Hopkins University · R01 · FY2017 · NS
SIV-induced Inflammation Causes Functional Impairment of the PNS
$740,714Joseph L Mankowski · Johns Hopkins University · R01 · FY2019 · NS
ILC2s as drivers of lung dysfunction in response to early-life inflammation
$740,709Anna E Beaudin · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$740,687Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2025 · HL
KLF2 is a novel endoprotective target for DKD
$740,566John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK